Oral manifestations, risk factors and management strategies of COVID-19 associated mucormycosis in tertiary care hospital
Conclusions: Mucormycosis can cause serious oro-facial morbidity and mortality in COVID-19 patients. The current management strategy requires early diagnosis, prompt treatment and oral rehabilitation.
Source: Indian Journal of Dental Research - Category: Dentistry Authors: Pankaj Goel Jitendra Kumar Anshul Rai Prateek Shakti Gunjan Chouksey Source Type: research
More News: Brain | COVID-19 | Dentistry | Diabetes | Diabetes Mellitus | Diabetic Ulcers | Endocrinology | India Health | Infectious Diseases | Neurology | Outbreaks | Pain | Pain Management | Pandemics | Rehabilitation | Statistics | Steroid Therapy | Study | Thrombosis